The estimated Net Worth of Judith C Pelham is at least $2.52 Milhão dollars as of 8 February 2018. Judith Pelham owns over 2,142 units of Welltower stock worth over $1,612,882 and over the last 21 years Judith sold WELL stock worth over $908,314.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Judith Pelham WELL stock SEC Form 4 insiders trading
Judith has made over 11 trades of the Welltower stock since 2003, according to the Form 4 filled with the SEC. Most recently Judith exercised 2,142 units of WELL stock worth $275,590 on 8 February 2018.
The largest trade Judith's ever made was exercising 47,200 units of Welltower stock on 28 July 2003 worth over $623,512. On average, Judith trades about 4,169 units every 171 days since 2003. As of 8 February 2018 Judith still owns at least 12,536 units of Welltower stock.
You can see the complete history of Judith Pelham stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Judith Pelham's mailing address?
Judith's mailing address filed with the SEC is ONE AMGEN CENTER DRIVE, , THOUSAND OAKS, CA, 91320-1799.
Insiders trading at Welltower
Over the last 7 years, insiders at Welltower have traded over $2,063,553 worth of Welltower stock and bought 3,587 units worth $192,115 . The most active insiders traders include Timothy J Naughton, R Scott Trumbull, ePhilip L Hawkins. On average, Welltower executives and independent directors trade stock every 56 days with the average trade being worth of $1,023,748. The most recent stock trade was executed by Kenneth J Bacon on 4 June 2024, trading 1,800 units of WELL stock currently worth $187,038.
What does Welltower do?
health care reit, inc. is now welltower™ welltower™ is a recognized leader in providing consistent, low-cost capital to fund health care infrastructure and real estate. our business structure as a publically traded reit (nyse:hcn) provides us with opportunities to fund innovative solutions designed to keep patients out of higher cost, higher acuity settings while delivering better treatment at lower cost. global demographic and social trends, notably the aging of the population, require vast investments and infrastructure development. the devastating impact of dementia on people and their families demands new solutions. together with our operating partners, we’re creating environments that help our partners meet the challenges of this complicated and rapidly changing market. welltower™ partners with some of the most innovative health systems and seniors housing operators to grow their platforms and support the evolution of health care. together with our partners, we seek to drive
What does Welltower's logo look like?
Complete history of Judith Pelham stock trades at AMGEN e Welltower
Welltower executives and stock owners
Welltower executives and other stock owners filed with the SEC include:
-
Shankh Mitra,
Chief Executive Officer, Chief Investment Officer, Director -
Timothy McHugh,
Chief Financial Officer, Executive Vice President -
Shankh S. Mitra,
CEO, Chief Investment Officer & Director -
Matthew McQueen,
Senior Vice President, General Counsel, Corporate Secretary -
Timothy G. McHugh,
Exec. VP & CFO -
Matthew Grant McQueen J.D.,
Exec. VP, Gen. Counsel & Corp. Sec. -
Ayesha M. Menon,
Sr. VP of Wellness Housing and Devel. -
Jeffrey Donahue,
Lead Independent Director -
Sharon Oster,
Independent Director -
Sergio Rivera,
Independent Director -
Kenneth Bacon,
Non-Executive Chairman of the Board -
Johnese Spisso,
Independent Director -
Kathryn Sullivan,
Independent Director -
Karen DeSalvo,
Independent Director -
Diana Reid,
Director -
Philip Hawkins,
Director -
Nicholas Rumanes,
Vice President - Head of Development -
Ryan Rothacker,
Vice President - Portfolio Management & Operations -
Justin Skiver,
Senior Vice President, Global Head of Seniors Housing -
Ayesha Menon,
Senior Vice President - Strategic Investments -
John Olympitis,
Sr. VP & Head of Corp. Devel. -
Pam Byrne,
Sr. VP & Head of Human Capital -
Mary Ellen Pisanelli,
Sr. VP of Legal & Admin. -
Krishna Soma,
VP of Corp. Fin. -
Joshua T. Fieweger,
Sr. VP & Chief Accounting Officer -
John F. Burkart,
Exec. VP & COO -
Thomas J Derosa,
Chairman & CEO -
John Goodey,
Chief Financial Officer -
Mercedes Kerr,
EVP-Business Development -
Gary Whitelaw,
Director -
R Scott Trumbull,
Director -
Judith C Pelham,
Director -
Timothy J Naughton,
Director -
Geoffrey G Meyers,
Director -
John F. Burkart,
EVP-Chief Operating Officer -
Andrew Gundlach,
-
Ade J. Patton,
-
Dennis G Lopez,
-
Joshua Fieweger,
SVP, Chief Accounting Officer